Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

A quality improvement initiative to increase Tdap (tetanus, diphtheria, acellular pertussis) vaccination coverage among direct health care providers at a children's hospital.

Jiang C, Whitmore-Sisco L, Gaur AH, Adderson EE; Tdap Working Group.

Vaccine. 2018 Jan 4;36(2):214-219. doi: 10.1016/j.vaccine.2017.11.071. Epub 2017 Dec 6.

PMID:
29217370
2.

The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia.

Sykes A, Gerhardt E, Tang L, Adderson EE.

J Pediatr. 2017 Dec;191:218-224.e1. doi: 10.1016/j.jpeds.2017.08.071.

3.

Epidemiology of Diarrheal Illness in Pediatric Oncology Patients.

Mhaissen MN, Rodriguez A, Gu Z, Zhu H, Tang L, Sun Y, Schultz-Cherry ST, Hayden RT, Adderson EE.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):275-280. doi: 10.1093/jpids/piw050.

PMID:
27578209
4.

Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.

Apiwattankul N, Flynn PM, Hayden RT, Adderson EE.

J Pediatric Infect Dis Soc. 2015 Jun;4(2):104-13. doi: 10.1093/jpids/piu038. Epub 2014 May 7. Review.

5.

Distinguishing Osteomyelitis From Ewing Sarcoma on Radiography and MRI.

McCarville MB, Chen JY, Coleman JL, Li Y, Li X, Adderson EE, Neel MD, Gold RE, Kaufman RA.

AJR Am J Roentgenol. 2015 Sep;205(3):640-50; quiz 651. doi: 10.2214/AJR.15.14341.

6.

The Impact of Vaccine Concerns on Racial/Ethnic Disparities in Influenza Vaccine Uptake Among Health Care Workers.

Ojha RP, Stallings-Smith S, Flynn PM, Adderson EE, Offutt-Powell TN, Gaur AH.

Am J Public Health. 2015 Sep;105(9):e35-41. doi: 10.2105/AJPH.2015.302736. Epub 2015 Jul 16.

7.

Distinguishing Benign Mediastinal Masses from Malignancy in a Histoplasmosis-Endemic Region.

Naeem F, Metzger ML, Arnold SR, Adderson EE.

J Pediatr. 2015 Aug;167(2):409-15. doi: 10.1016/j.jpeds.2015.04.066. Epub 2015 May 23.

8.

Imaging of acute invasive fungal rhinosinusitis in a patient with gorlin syndrome and acute lymphocytic leukemia.

Donovan ST, Thompson JW, Sandlund JT, Adderson EE, Pivnick EK, Harreld JH.

Case Rep Otolaryngol. 2013;2013:272314. doi: 10.1155/2013/272314. Epub 2013 Jun 18.

9.

The safety of cefepime and ceftazidime in pediatric oncology patients.

Hoffman JM, Frediani J, Herr M, Flynn PM, Adderson EE.

Pediatr Blood Cancer. 2013 May;60(5):806-9. doi: 10.1002/pbc.24467. Epub 2013 Feb 4.

10.

Clinical and demographic characteristics of seasonal influenza in pediatric patients with cancer.

Carr SB, Adderson EE, Hakim H, Xiong X, Yan X, Caniza M.

Pediatr Infect Dis J. 2012 Nov;31(11):e202-7. doi: 10.1097/INF.0b013e318267f7d9.

11.

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.

Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM.

J Infect Dis. 2011 Nov 15;204(10):1475-82. doi: 10.1093/infdis/jir561. Epub 2011 Sep 23.

PMID:
21949042
12.

Phylogenetic lineage and pilus protein Spb1/SAN1518 affect opsonin-independent phagocytosis and intracellular survival of Group B Streptococcus.

Chattopadhyay D, Carey AJ, Caliot E, Webb RI, Layton JR, Wang Y, Bohnsack JF, Adderson EE, Ulett GC.

Microbes Infect. 2011 Apr;13(4):369-382. doi: 10.1016/j.micinf.2010.12.009. Epub 2011 Jan 14.

13.

Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.

Carr S, Ilyushina NA, Franks J, Adderson EE, Caniza M, Govorkova EA, Webster RG.

Pediatr Infect Dis J. 2011 Apr;30(4):284-8. doi: 10.1097/INF.0b013e3181ff863b.

14.

Priming the immune system for heart disease: a perspective on group A streptococci.

Ellis NM, Kurahara DK, Vohra H, Mascaro-Blanco A, Erdem G, Adderson EE, Veasy LG, Stoner JA, Tam E, Hill HR, Yamaga K, Cunningham MW.

J Infect Dis. 2010 Oct 1;202(7):1059-67. doi: 10.1086/656214.

PMID:
20795820
15.

Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysis.

Adderson EE, Flynn PM, Hoffman JM.

J Pediatr. 2010 Sep;157(3):490-5, 495.e1. doi: 10.1016/j.jpeds.2010.03.023. Review.

PMID:
20434167
16.

Zygomycosis originating from an odontogenic infection in a pediatric oncology patient.

Adderson EE, Rowland C, McGregor LM, Santana VM.

Diagn Microbiol Infect Dis. 2010 May;67(1):92-4. doi: 10.1016/j.diagmicrobio.2009.12.016. Epub 2010 Mar 12.

17.

Association between nutritional status and severity of dengue infection in children in El Salvador.

Marón GM, Clará AW, Diddle JW, Pleités EB, Miller L, Macdonald G, Adderson EE.

Am J Trop Med Hyg. 2010 Feb;82(2):324-9. doi: 10.4269/ajtmh.2010.09-0365.

18.

Infections caused by coryneform bacteria in pediatric oncology patients.

Adderson EE, Boudreaux JW, Hayden RT.

Pediatr Infect Dis J. 2008 Feb;27(2):136-41. doi: 10.1097/INF.0b013e31814fab12.

PMID:
18174873
19.

Identification of clinical coryneform bacterial isolates: comparison of biochemical methods and sequence analysis of 16S rRNA and rpoB genes.

Adderson EE, Boudreaux JW, Cummings JR, Pounds S, Wilson DA, Procop GW, Hayden RT.

J Clin Microbiol. 2008 Mar;46(3):921-7. Epub 2007 Dec 26.

20.

L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.

Aoyagi Y, Adderson EE, Rubens CE, Bohnsack JF, Min JG, Matsushita M, Fujita T, Okuwaki Y, Takahashi S.

Infect Immun. 2008 Jan;76(1):179-88. Epub 2007 Oct 15.

21.

Failure of viridans group streptococci causing bacteremia in pediatric oncology patients to express superantigens.

Ohuoba EF, Kansal RG, Hayden RT, Kotb M, Adderson EE.

J Pediatr Hematol Oncol. 2006 Sep;28(9):627-9.

PMID:
17006272
22.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616
23.
24.

A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae.

Seifert KN, Adderson EE, Whiting AA, Bohnsack JF, Crowley PJ, Brady LJ.

Microbiology. 2006 Apr;152(Pt 4):1029-40.

PMID:
16549667
25.

Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

Avadhanula V, Rodriguez CA, Devincenzo JP, Wang Y, Webby RJ, Ulett GC, Adderson EE.

J Virol. 2006 Feb;80(4):1629-36.

26.
27.

Mechanisms of group B streptococcal-induced apoptosis of murine macrophages.

Ulett GC, Maclean KH, Nekkalapu S, Cleveland JL, Adderson EE.

J Immunol. 2005 Aug 15;175(4):2555-62.

28.

Infections in children and young adults with bone malignancies undergoing limb-sparing surgery.

Gaur AH, Liu T, Knapp KM, Daw NC, Rao BN, Neel MD, Rodriguez-Galindo C, Brand D, Adderson EE.

Cancer. 2005 Aug 1;104(3):602-10.

29.

Nitric oxide is a key determinant of group B streptococcus-induced murine macrophage apoptosis.

Ulett GC, Adderson EE.

J Infect Dis. 2005 May 15;191(10):1761-70. Epub 2005 Apr 13.

PMID:
15838805
30.

Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci.

Aoyagi Y, Adderson EE, Min JG, Matsushita M, Fujita T, Takahashi S, Okuwaki Y, Bohnsack JF.

J Immunol. 2005 Jan 1;174(1):418-25.

31.

Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections.

Bohnsack JF, Whiting AA, Martinez G, Jones N, Adderson EE, Detrick S, Blaschke-Bonkowsky AJ, Bisharat N, Gottschalk M.

Emerg Infect Dis. 2004 Aug;10(8):1412-9.

32.

Myositis complicating viridans streptococcal sepsis in childhood leukemia.

Sandlund JT, Howard SC, Hijiya N, Pui CH, Shenep JL, Adderson EE.

Pediatr Blood Cancer. 2005 Mar;44(3):277-9.

PMID:
15468304
33.

Equivalence of high-virulence clonotypes of serotype III group B Streptococcus agalactiae (GBS).

Fleming KE, Bohnsack JF, Palacios GC, Takahashi S, Adderson EE.

J Med Microbiol. 2004 Jun;53(Pt 6):505-8.

PMID:
15150329
34.

Histoplasmosis in a pediatric oncology center.

Adderson EE.

J Pediatr. 2004 Jan;144(1):100-6.

PMID:
14722526
35.
36.

Beta-hemolysin-independent induction of apoptosis of macrophages infected with serotype III group B streptococcus.

Ulett GC, Bohnsack JF, Armstrong J, Adderson EE.

J Infect Dis. 2003 Oct 1;188(7):1049-53. Epub 2003 Sep 15.

PMID:
14513426
37.

Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas.

O'Neill JM, St Geme JW 3rd, Cutter D, Adderson EE, Anyanwu J, Jacobs RF, Schutze GE.

J Clin Microbiol. 2003 Jul;41(7):3064-9.

38.

Pgi genotyping is a surrogate for serotyping of encapsulated Haemophilus influenzae.

Anyanwu JN, Rodriguez CA, Fleming KE, Adderson EE.

J Clin Microbiol. 2003 May;41(5):2080-3.

39.

Prevalence and distribution of adhesins in invasive non-type b encapsulated Haemophilus influenzae.

Rodriguez CA, Avadhanula V, Buscher A, Smith AL, St Geme JW 3rd, Adderson EE.

Infect Immun. 2003 Apr;71(4):1635-42.

40.

Successful treatment of disseminated fusariosis.

Rodriguez CA, Luján-Zilbermann J, Woodard P, Andreansky M, Adderson EE.

Bone Marrow Transplant. 2003 Mar;31(5):411-2. No abstract available.

PMID:
12634735
41.

Correlation of phylogenetic lineages of group B Streptococci, identified by analysis of restriction-digestion patterns of genomic DNA, with infB alleles and mobile genetic elements.

Takahashi S, Detrick S, Whiting AA, Blaschke-Bonkowksy AJ, Aoyagi Y, Adderson EE, Bohnsack JF.

J Infect Dis. 2002 Oct 1;186(7):1034-8. Epub 2002 Sep 13.

PMID:
12232847
42.

Limited genetic diversity of recent invasive isolates of non-serotype b encapsulated Haemophilus influenzae.

Omikunle A, Takahashi S, Ogilvie CL, Wang Y, Rodriguez CA, St Geme JW 3rd, Adderson EE.

J Clin Microbiol. 2002 Apr;40(4):1264-70.

43.

Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations.

Adderson EE.

Springer Semin Immunopathol. 2001 Dec;23(4):387-403. Review.

PMID:
11826616
44.

Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type III-3 reveals clustering of virulence genes.

Bohnsack JF, Whiting AA, Bradford RD, Van Frank BK, Takahashi S, Adderson EE.

Infect Immun. 2002 Jan;70(1):134-9.

45.

Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era?

Adderson EE, Byington CL, Spencer L, Kimball A, Hindiyeh M, Carroll K, Mottice S, Korgenski EK, Christenson JC, Pavia AT.

Pediatrics. 2001 Jul;108(1):E18.

PMID:
11433097
46.

Capsulation loci of non-serotype b encapsulated Haemophilus influenzae.

Ogilvie C, Omikunle A, Wang Y, St Geme III JW 3rd, Rodriguez CA, Adderson EE.

J Infect Dis. 2001 Jul 15;184(2):144-9. Epub 2001 Jun 8.

PMID:
11424010
47.

Phylogenetic classification of serotype III group B streptococci on the basis of hylB gene analysis and DNA sequences specific to restriction digest pattern type III-3.

Bohnsack JF, Takahashi S, Detrick SR, Pelinka LR, Hammitt LL, Aly AA, Whiting AA, Adderson EE.

J Infect Dis. 2001 Jun 1;183(11):1694-7. Epub 2001 Apr 23.

PMID:
11343222
48.

Molecular analysis of cross-reactive anti-myosin/anti-streptococcal mouse monoclonal antibodies.

Mertens NM, Galvin JE, Adderson EE, Cunningham MW.

Mol Immunol. 2000 Oct;37(15):901-13.

PMID:
11282394
49.

Growth failure, intracranial calcifications, acquired pancytopenia, and unusual humoral immunodeficiency: a genetic syndrome?

Adderson EE, Viskochil DH, Carey JC, Shigeoka AO, Christenson JC, Bohnsack JF, Hill HR.

Am J Med Genet. 2000 Nov 6;95(1):17-20.

PMID:
11074489
50.

Bacterial genetics and human immunity to group B streptococci.

Adderson EE, Takahashi S, Bohnsack JF.

Mol Genet Metab. 2000 Sep-Oct;71(1-2):451-4. Review.

PMID:
11001839

Supplemental Content

Loading ...
Support Center